The Latest Updates from CNSide Diagnostics
The American Journal of Managed Care: Advancing Innovation in CNS Cancer Treatment and Diagnostics
Each year, approximately 110,000 people in the United States are affected by leptomeningeal metastases (LM) — a devastating complication of advanced cancers such as breast, lung, and melanoma. Despite its prevalence, treatment options remain limited, costly, and often...
Growth at Our New CNSide Houston Facility
Our CNSide Diagnostics lab team brought some Halloween fun to our new Houston facility at Levit Green — a creative and spirited way to celebrate as we continue to build momentum in our new space! Beyond the costumes and candy, this moment reflects a larger milestone...
Welcoming Nikki Taylor to the CNSide Diagnostics Team
CNSide Diagnostics is excited to welcome Nikki Taylor, BS, RT(R), RDMS, RVT to our growing team as Inside Sales Representative. Nikki brings extensive experience in medical imaging, diagnostics, and patient engagement, as well as a strong background in radiologic and...
Plus Therapeutics and CNSide Diagnostics Join the Head for the Cure 5K to Support Brain Cancer Research
Last weekend, members of the Plus Therapeutics and CNSide Diagnostics teams, led by Gabby Cleveland, participated in the 7th Annual Head for the Cure Foundation 5K in Phoenix, Arizona — running and walking in support of brain cancer research and awareness. This event...
Plus Therapeutics Advances Commercial Launch of CNSide Diagnostics and Expands Leadership to Accelerate Growth
Plus Therapeutics (NASDAQ: PSTV) announced continued operational execution and commercial progress in the launch of its wholly owned subsidiary, CNSide Diagnostics, and its Cerebrospinal Fluid (CSF) Tumor Cell Enumeration laboratory-developed test (LDT). Recent...
Welcoming Elizabeth Hernandez to the CNSide Diagnostics Team
CNSide Diagnostics is pleased to announce the addition of Elizabeth Hernandez as Laboratory Operations Coordinator. Elizabeth brings valuable experience in laboratory management and operational excellence to our growing team — supporting CNSide’s mission to advance...
CNSide Featured at BioHouston’s October Event
Last week, CNSide Diagnostics Medical Director Jonathan Stein, PhD, HCLD(ABB) presented at BioHouston’s October Life Science event — joining an incredible community of innovators, entrepreneurs, and researchers driving the future of biotechnology and diagnostics...
CNSide Recognizes Metastatic Breast Cancer Awareness Day
Today marks Metastatic Breast Cancer Awareness Day — a day dedicated to honoring those living with advanced breast cancer and the families, researchers, and advocates working tirelessly to improve their care and outcomes. We’re spotlighting an important discussion...
LiveLung Webinar to Spotlight Leptomeningeal Metastases with Stanford Neuro-Oncologist Dr. Seema Nagpal
LiveLung will host its monthly patient education webinar, featuring Seema Nagpal, M.D., Neuro-Oncologist at Stanford Health Care, for an in-depth discussion on Leptomeningeal Metastases (LM) — a challenging and often underdiagnosed complication of advanced cancers....
CNSide Team Supports Cancer Research at the Winship 5K During Breast Cancer Awareness Month
This past weekend, CNSide Diagnostics’ Andrew Sims and Conroy Campbell proudly participated in the Winship 5K in support of the Winship Cancer Institute of Emory University and its mission to advance lifesaving cancer research. Held during Breast Cancer Awareness...